Ergoteles’s Cue Health Inc. Common Stock HLTH Stock Holding History

Ergoteles’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-56,300	Closed	-$363K	–	2091
2022 Q1	$363K	Buy	+56,300	New	+$509K	0.01%	781

Other funds holding HLTH

Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return

Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JPC

Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles's HLTH Position: Q2 2022 in Review

Ergoteles sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2022, closing a stake of 56,300 shares — an estimated $363K sold.

Ergoteles first reported a position in HLTH in Q1 2022 and held it in 1 quarter. The position peaked at $363K in Q1 2022. 99 funds tracked by Wall St. Rank hold HLTH as of Q2 2022.

Ergoteles reported no remaining Cue Health Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ergoteles sold 56,300 Cue Health Inc. Common Stock shares in Q2 2022, an estimated $363K.
Ergoteles first reported a position in Cue Health Inc. Common Stock in Q1 2022 and held it in 1 quarter.
Ergoteles's Cue Health Inc. Common Stock position peaked at $363K in Q1 2022.
99 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2022.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.